Northwestern Mutual Wealth Management
VBIO

Northwestern Mutual Wealth Management’s Valion Bio VBIO Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio VBIO Stock Details VBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3
Closed -$90 – 3809
2023
Q4 		$90 Buy
+3
New +$86 ﹤0.01% 3386

Other funds holding VBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northwestern Mutual Wealth Management's VBIO Position: Q1 2024 in Review

Northwestern Mutual Wealth Management sold out of Valion Bio (VBIO) in Q1 2024, closing a stake of 3 shares — an estimated $90 sold.

Northwestern Mutual Wealth Management first reported a position in VBIO in Q4 2023 and held it in 1 quarter. The position peaked at $90 in Q4 2023. 5 funds tracked by Wall St. Rank hold VBIO as of Q1 2024.

  • Northwestern Mutual Wealth Management reported no remaining Valion Bio position as of Q1 2024 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 3 Valion Bio shares in Q1 2024, an estimated $90.
  • Northwestern Mutual Wealth Management first reported a position in Valion Bio in Q4 2023 and held it in 1 quarter.
  • Northwestern Mutual Wealth Management's Valion Bio position peaked at $90 in Q4 2023.
  • 5 funds tracked by Wall St. Rank held Valion Bio as of Q1 2024.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2024, filed 15 May 2024.